Chinese Rhubarb for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Chinese Rhubarb for Health & Longevity

Created on 07/14/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

Chinese rhubarb is a traditional root remedy best established as a short-term laxative. Small, low-quality studies hint it may slow kidney decline, ease recovery from severe pancreas inflammation, help control upper digestive bleeding, and modestly improve cholesterol. Against these sit cramping, salt loss, kidney-stone risk, and organ strain at high doses. (Full Review)

Protocol

Dose
20–50 mg/kg daily
Standardized root extract, short-term
Timing
Evening
Effect arrives the following morning
Duration
Short courses
Occasional or brief use, not daily maintenance
Time to effect
Constipation relief
6–12 hours
Laxative onset
Kidney function
Weeks–months
Chronic kidney disease use
Pancreatitis recovery
2–4 days
Shorter hospital stay

Benefits

Contraindications
  • Pregnancy and breastfeeding
  • Children
  • Bowel obstruction or undiagnosed acute abdomen
  • Active inflammatory bowel disease (Crohn's, ulcerative colitis in flare)
  • Appendicitis or undiagnosed abdominal pain
  • History of calcium-oxalate kidney stones or gout
  • Significant liver disease
    •
Key Interactions
  • Cardiac glycosides (digoxin)
  • Diuretics and corticosteroids (furosemide, hydrochlorothiazide, prednisone)
  • Oral medications generally
  • Anticoagulants and antiplatelet drugs (warfarin, aspirin, clopidogrel)
  • Other stimulant laxatives (senna, cascara, bisacodyl)
  • Additive supplements (magnesium, high-dose vitamin C)
    •

Risk & Side Effects

  • High: Abdominal cramping and diarrhea; electrolyte depletion
    •
  • Medium: Melanosis coli; oxalate load and kidney-stone risk
    •
  • Low: Liver and kidney injury at high doses; dependence with chronic use
    •
  • Speculative: Emodin genotoxicity and carcinogenicity; reproductive and developmental effects
    •

Monitoring

Marker Target Why
Potassium 4.0–4.5 mmol/L Detects laxative-driven depletion
Creatinine / eGFR eGFR >90 mL/min/1.73m² Tracks kidney function and any paradoxical strain
Blood urea nitrogen (BUN) 10–16 mg/dL Reflects nitrogen-waste clearance targeted in kidney use
Urinary oxalate <40 mg/24h Flags stone risk from rhubarb's oxalate load
ALT / AST ALT <25 U/L, AST <25 U/L Screens for high-dose anthraquinone liver strain

Cadence: Baseline, 4–6 weeks, then every 3–6 months during extended or therapeutic use

Qualitative Assessment

  • Comfortable, regular bowel movements without cramping or urgency
  • Stable energy and absence of muscle weakness or cramps
  • No new flank pain or urinary symptoms suggestive of stones
  • For kidney use, stable or improving lab trends rather than symptom change alone
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.